Table 3 Comparison of clinical characteristics (age, BMI, stage, histological classification) and intensity of TF expression between patients with VTE (n=10) and without VTE (n=22)
From: Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer
VTE (−) n =22 | VTE (+) n =10 | P | |
|---|---|---|---|
(mean±s.d.) | |||
Age (years) | 47.9 ± 13.9 | 54.0 ± 12.9 | 0.0782 |
BMI | 24.0 ± 4.6 | 21.7 ± 2.4 | 0.9171 |
FIGO stage (number of subjects) | |||
Stage I (n=7) | 6 | 1 | 0.1065 |
Stage II (n=6) | 3 | 3 | |
Stage III (n=11) | 8 | 3 | |
Stage IV (n=8) | 5 | 3 | |
Histological classification (number of subjects) | |||
Non-clear cell (n=21) | 16 | 5 | 0.2515 |
Clear cell (n=11) | 6 | 5 | |
Intensity of TF expression (number of subjects) | |||
Negative (n=5) | 5 | 0 | 0.0003 |
Weakly positive (n=9) | 9 | 0 | |
Moderately positive (n=10) | 5 | 5 | |
Strongly positive (n=8) | 3 | 5 | |
